International Clinical Trial: A randomized, double-blind, placebo-controlled Phase Ib/II clinical study to evaluate the safety, tolerability, pharmacokinetic profiles and efficacy of multiple administrations of NH104 Tablets in adult patients with insomnia disorder

Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134007) titled 'A randomized, double-blind, placebo-controlled Phase Ib/II clinical study to evaluate the safety, tolerability, pharmacokinetic profiles and efficacy of multiple administrations of NH104 Tablets in adult patients with insomnia disorder' on Oct. 10.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking University Sixth Hospital ( Institute of Mental Health )

Condition: Insomnia Disorder

Intervention: Stage Ib - Drug Group:After being screened and deemed eligible, trial participants entered a dose-escalation study with the following dose groups: 20, 40, 80, and 100 mg. Participants ...